Form 4: MYGN CFO Sells Shares for Tax Obligations

Myriad Genetics CFO Benjamin Wheeler disposed of 21 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc. (MYGN), reported a transaction on December 25, 2025.
• The transaction involved the disposition of 21 shares of common stock.
• These shares were withheld by the company to satisfy tax withholding obligations associated with the vesting of restricted stock units granted to Mr. Wheeler.
• The price per share for the disposition was $6.55, determined by the closing price of Myriad common stock on December 24, 2025.
• Following this transaction, Mr. Wheeler beneficially owns 92,630 shares of Myriad Genetics common stock directly.

Sentiment

Score: 5

Explanation: This is a neutral filing reporting a routine insider transaction for tax purposes, which has no material impact on the company's operations or financial health.

Stakeholder Impact

• Shareholders: Minimal to no direct impact due to the small, routine nature of the transaction.
• Employees: No direct impact.

Key Dates

Keywords

Myriad Genetics, MYGN, Form 4, Insider Transaction, CFO, Benjamin Wheeler, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation